The availability of comprehensive data on clinicians and therapeutic areas in the US enables innovative, cost-effective solutions like Alpha Sophia to drive smarter go-to-market and territory decisions.
In the latest episode of the Alpha Sophia Spotlight Podcast, we had an insightful discussion with Nicholas Rosen, CEO from Exaris Solutions, about the stark contrast in Europe. Over there, data access is much more challenging and costly due to the lack of readily available information.
🎧 Tune in to the full episode to discover how Exaris Solutions is tackling this significant hurdle in the European market and the creative strategies they’re employing to overcome it.
Fill out the form and we will help you with your HCP engagement strategy.
AI for Life Science